Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02743221 |
|---|---|
| Brief Title: | A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy (TASCO1) |
| First Submitted : | February 24, 2016 |
| First Submitted that Met QC Criteria : | April 14, 2016 |
| First Posted : | April 19, 2016 (Estimate) |
| Results First Submitted : | January 15, 2019 |
| Results First Submitted that Met QC Criteria : | March 25, 2019 |
| Results First Posted : | April 16, 2019 |
| Last Update Submitted that Met QC Criteria : | October 3, 2021 |
| Last Update Posted : | October 5, 2021 |